The Euro-Global Platform for Mechanism-based Drug Repurposing
From low precision drug therapy to high precision curative therapy through real-world data, Artificial Intelligence and a platform offering every step from lab to phase II clinical
What we do
Network Medicine
Overcoming the roadblocks
From imprecision to precision medicine
The context
+60%
of newly registered drugs fail to provide benefit over existing drugs
Drug companies need to start curing, those who keep treating will disappear
CEO Novartis
Our Platform
Whether you need bioinformatics support for an unmet medical need, a registered compound, search a mechanism, explore your freedom to operate, need a patenting strategy or regulatory advice, need a business partner, a clinical trial test site for phase I-III or help with a business plan or all of this, we have the experts and global experience to help and work with you
Bioinformatics
In silico disease modeling
Virtual patient
Artificial Intelligence
Repurposing
Broad drug repurposing experience
Mechanism drug repurposing
De novo signaling module construction
New paradigm
For drug repurposing and therapy
Less animal work
Focus on point of care diagnostics for patient stratification and precision therapy
